Paediatric biopharmaceutics classification system: Current status and future decisions

被引:32
作者
Batchelor, Hannah [1 ]
机构
[1] Univ Birmingham, Pharm Pharmacol & Therapeut Sect, Birmingham B15 2TT, W Midlands, England
关键词
Paediatric; Biopharmaceutics; Solubility; Dose number; CHILDREN; VOLUME; PH;
D O I
10.1016/j.ijpharm.2014.02.046
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Biopharmaceutical methods are routinely used in the design of medicines to predict in vivo absorption and hence guide the development of new products. Differences in anatomy and physiology of paediatric patients require adaptation of existing biopharmaceutical methods to ensure that in vivo predictions are relevant for this population. The biopharmaceutics classification system is a tool used in drug development to guide formulation selection and manufacture from early clinical studies through to product launch. The applicability of the biopharmaceutics system to paediatric product development has yet to be explored; this note brings together some key issues in direct extrapolation from adults into paediatric populations. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:251 / 253
页数:3
相关论文
共 21 条
[1]   Summary of the National Institute of Child Health and Human Development-Best Pharmaceuticals for Children Act Pediatric Formulation Initiatives Workshop-Pediatric Biopharmaceutics Classification System Working Group [J].
Abdel-Rahman, Susan M. ;
Amidon, Gordon L. ;
Kaul, Ajay ;
Lukacova, Viera ;
Vinks, Alexander A. ;
Knipp, Gregory T. .
CLINICAL THERAPEUTICS, 2012, 34 (11) :S11-S24
[2]   Pediatric Dose Selection [J].
Abernethy, D. R. ;
Burckart, G. J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (03) :270-271
[3]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[4]  
[Anonymous], 2012, British National Formulary
[5]  
[Anonymous], 2010, CPMPEWPQWP140198
[6]   Application of in vitro biopharmaceutical methods in development of immediate release oral dosage forms intended for paediatric patients [J].
Batchelor, Hannah K. ;
Kendall, Richard ;
Desset-Brethes, Sabine ;
Alex, Rainer ;
Ernest, Terry B. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 85 (03) :833-842
[7]  
CRAWFORD M, 1990, ANESTH ANALG, V71, P400
[8]   Prediction of Solubility and Permeability Class Membership: Provisional BCS Classification of the World's Top Oral Drugs [J].
Dahan, Arik ;
Miller, Jonathan M. ;
Amidon, Gordon L. .
AAPS JOURNAL, 2009, 11 (04) :740-746
[9]  
European Medicines Agency (EMA), 2001, CPMPICH271199 EMA
[10]  
FDA, 2000, GUID IND WAIV VIV BI